Dear Brightly Night ShiftvsMusely The Spot Cream (FaceRx)

The active ingredient is tretinoin, an FDA-approved retinoid that binds retinoic acid receptors in skin cells to speed cell turnover, boost collagen production, and even out pigmentation, which collectively smooths fine lines and refines texture over months. Dear Brightly suspends it in a vehicle with niacinamide and silicone-based emollients designed to slow release and limit the transepidermal water loss that drives early irritation. A licensed provider sets the tailored strength.

The Spot Cream is a pharmacist-compounded topical built around hydroquinone, which blocks the enzyme tyrosinase to slow melanin production. Musely layers in tretinoin to speed cell turnover and push pigmented cells out faster while improving penetration of the other actives, plus tranexamic acid, kojic acid, and niacinamide, which interrupt pigment formation and transfer through complementary pathways. The exact concentrations are tailored by the prescriber to your skin and concern.

Topical tretinoin has among the strongest evidence bases in dermatology: multiple randomized controlled trials and meta-analyses show significant improvement in fine and coarse wrinkles, mottled pigmentation, and roughness versus vehicle, with benefits emerging within weeks and building over 6 to 12 months. The specific Night Shift formula is not separately trialed, so efficacy claims rest on tretinoin itself. Individual results vary.

Hydroquinone remains the most studied and effective topical for melasma, and systematic reviews confirm meaningful pigment reduction; combining it with tretinoin and tranexamic acid has shown additive benefit in controlled trials. Musely itself has not published independent head-to-head clinical trials of its specific compounded blend, so evidence rests on the established performance of the individual ingredients. Most users see fading over 8 to 12 weeks. Individual results vary.

Expect a retinization period of dryness, flaking, redness, and possible mild stinging during the first several weeks; this typically eases as skin adapts. Tretinoin increases sun sensitivity, so daily broad-spectrum SPF is essential. Introduce it slowly, a few nights per week to start. Contact your provider if irritation becomes severe or persistent.

Expect an adjustment period with redness, dryness, and peeling from the tretinoin component, plus heightened sun sensitivity. Hydroquinone is intended for limited courses (typically a few months at a time) because prolonged continuous use raises the rare risk of exogenous ochronosis, a paradoxical darkening. Daily broad-spectrum SPF is essential. Stop and contact your provider if you develop severe irritation.

As of 2026, the first order is a $66 trial covering a two-month supply with free shipping, after which refills bill at $99 per quarter for roughly a three-month supply (about $33/month). The telehealth review is included in the price. It is not covered by insurance, and you can change frequency or cancel anytime.

As of 2026, the subscription price is $67 per two-month supply (about $33.50/month) with a one-time $20 first-visit fee; the one-time non-subscription price is $96. Not covered by insurance. Because it bundles agents that would otherwise be separate prescriptions, the per-ingredient value is reasonable, but the recurring auto-refill should be managed actively.

Adults seeking anti-aging, texture, or tone improvement who can use a retinoid. Not for use during pregnancy or breastfeeding; a US-licensed provider screens your history and photos before prescribing.

Adults seeking treatment for melasma, dark spots, or hyperpigmentation. Not appropriate during pregnancy or breastfeeding due to tretinoin and hydroquinone, and a licensed provider screens for contraindications during the online visit.